Corporate Finance
Artiva Biotherapeutics faces capital shortfall risk ahead of pivotal NK cell therapy trials
ViaNews Editorial Team (Finance)•
#going concern
5 articles
Corporate Finance
Cardiff Oncology Burns Through $12M Per Quarter With 5 Quarters Of Cash Remaining
ViaNews Editorial Team (Finance)•
Corporate Finance Risk
Generation Mining faces cash crisis as Marathon Project stalls pre-production
ViaNews Editorial Team (Finance)•
Corporate Finance Risk
Sema4 faces going concern risk as reproductive health exit threatens revenue base
ViaNews Editorial Team (Finance)•
Corporate Finance
Biomerica Reports Cash Depletion Risk as Operating Losses Exceed Revenue
ViaNews Editorial Team (Finance)•